Clinical Trial Update: Smell Changes & Efficacy of Nasal Theophylline [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nasal theophylline for olfactory disorders/anosmia; completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Olfactory Disorder

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Olfactory Disorder, Anosmia | Phase 2 | Status: COMPLETED | Results posted: 2022-03-31